The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The prognostic and predictive impact of genomic grade index (GGI) versus central grade or molecular class in intermediate-risk breast cancer (BC): Results from the EC-Doc trial.
Oleg Gluz
No relevant relationships to disclose
Cornelia Liedtke
No relevant relationships to disclose
Helene P. Peyro Saint Paul
No relevant relationships to disclose
Ulrike Nitz
No relevant relationships to disclose
Ronald E. Kates
No relevant relationships to disclose
Jens Bodo Huober
No relevant relationships to disclose
Arndt Hartmann
No relevant relationships to disclose
Hans Heinrich Kreipe
No relevant relationships to disclose
Enrico Pelz
No relevant relationships to disclose
Ramona Erber
No relevant relationships to disclose
Walther Kuhn
No relevant relationships to disclose
Nadia Harbeck
No relevant relationships to disclose